Notify me when RAVI YANG SARIN files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TOI | The Oncology Institute, Inc. | Common Stock, par value $0.0001 per share | 4.7% | $11,959,434 | 4,109,771 | Ravi Sarin | 26 Mar 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|